Cargando…
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
Combination estrogen plus progestin causes breast cancer. In light of this causal relation, the rapid decline in breast cancer incidence noted in 2003, following an earlier and slower reduction in incidence from 1999, raises important issues regarding the proportion of this decline that may be due t...
Autor principal: | Colditz, Graham A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206710/ https://www.ncbi.nlm.nih.gov/pubmed/17666116 http://dx.doi.org/10.1186/bcr1736 |
Ejemplares similares
-
Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
por: Colditz, Graham A
Publicado: (2007) -
Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
por: Ward, Ashley V., et al.
Publicado: (2022) -
The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control—plus more
por: Shoupe, Donna
Publicado: (2023) -
The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors
por: Aupperlee, Mark D., et al.
Publicado: (2018) -
Postmenopausal estrogen and progestin effects on the serum proteome
por: Pitteri, Sharon J, et al.
Publicado: (2009)